Back to BlackRock, Inc.

CTKB
6 quarters

Position history for BlackRock, Inc.'s holdings in CYTEK BIOSCIENCES INC

BlackRock, Inc. holds 17M shares of CTKB (CYTEK BIOSCIENCES INC), worth $74.3M as of 2026-Q1. The position was decreased (-1.0% shares). CTKB represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$74.3M

Current Shares

17M

Total Value Change

-$45.6M

Total Shares Change

-1.5M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Decreased
17M
-1.0%
$74.3M0.0%$4.44
0
2025-Q4
Increased
17.2M
+3.8%
$86.7M0.0%$5.04
31
2025-Q3
Decreased
16.5M
-2.9%
$57.4M0.0%$3.38
0
2025-Q2
Decreased
17M
-5.7%
$57.9M0.0%$3.55
0
2025-Q1
Decreased
18.1M
-2.2%
$72.5M0.0%$4.00
0
2024-Q4
New
18.5M
-
$120M0.0%$6.55
42

Other major holders of CTKB: RA CAPITAL MANAGEMENT, L.P., HHLR ADVISORS, LTD., BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used